+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global PCOS Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025

  • ID: 5022580
  • Report
  • May 2020
  • Region: Global
  • 113 pages
  • TechSci Research
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Pcos Treatment Market is Expected to Grow at a Formidable Rate During the Forecast Period.

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • Bayer AG
  • EffRx Pharmaceuticals SA
  • Merck & Co., Inc.
  • Mylan N.V.
  • MORE
The Global PCOS Treatment Market is expected to grow at a formidable rate during the forecast period. The Global PCOS Treatment Market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, ongoing technological advancements and new product launches by the major players operating in the market for the development of new drugs and treatment options are anticipated to foster the growth of the market through 2025.

The Global PCOS Treatment Market is segmented based on treatment, diagnosis, end-user, company and region. Based on treatment the market can be bifurcated into surgeries and drug treatment. The surgeries segment can further be categorized into ovarian wedge resection and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of the segment across the globe.

Regionally, the Global PCOS Treatment Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast years in the Global PCOS Treatment Market et owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the Global PCOS Treatment Market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan N.V., Millendo Therapeutics, Inc. and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and estimate the market size of the Global PCOS Treatment Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global PCOS Treatment Market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast the Global PCOS Treatment Market based on treatment, diagnosis, end-user, company and regional distribution.
  • To identify dominant region or segment in the Global PCOS Treatment Market.
  • To identify drivers and challenges for the Global PCOS Treatment Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global PCOS Treatment Market.
  • To identify and analyze the profile of leading players operating in the Global PCOS Treatment Market.
  • To identify key sustainable strategies adopted by market players in the Global PCOS Treatment Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. The author analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

The author calculated the market size of the Global PCOS Treatment Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. They sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to PCOS treatment
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global PCOS Treatment Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global PCOS Treatment Market, By Treatment:
  • Surgeries
  • Ovarian Wedge Resection
  • Laparoscopic Ovarian Drilling
  • Drug Treatment
  • Oral Contraceptives
  • Antiandrogens
  • Anti-Depressants
  • Anti-Obesity Drugs
  • Others
Global PCOS Treatment Market, By Diagnosis:
  • Pelvic Examination
  • Ultrasound
  • Blood Tests
Global PCOS Treatment Market, By End-User:
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Fertility Clinics
Global PCOS Treatment Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape
  • Company Profiles: Detailed analysis of the major companies present in the Global PCOS Treatment Market.
Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. If you buy the ‘Multi-user’ License of this report before June 2020, you will get a free update in form of market data excel sheet within 3 to 6 months of your purchase on request.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • Bayer AG
  • EffRx Pharmaceuticals SA
  • Merck & Co., Inc.
  • Mylan N.V.
  • MORE
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Unmet Needs/Challenges

6. Global PCOS Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment (Surgeries v/s Drug Treatment)
6.2.1.1. By Surgeries (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling)
6.2.1.2. By Drug Treatment (Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
6.2.2. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
6.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
6.2.4. By Company (2019)
6.2.5. By Region
6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By Diagnosis
7.2.3. By End User
7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China PCOS Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment
7.3.1.2.2. By Diagnosis
7.3.1.2.3. By End User
7.3.2. India PCOS Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment
7.3.2.2.2. By Diagnosis
7.3.2.2.3. By End User
7.3.3. Australia PCOS Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment
7.3.3.2.2. By Diagnosis
7.3.3.2.3. By End User
7.3.4. Japan PCOS Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Treatment
7.3.4.2.2. By Diagnosis
7.3.4.2.3. By End User
7.3.5. South Korea PCOS Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Treatment
7.3.5.2.2. By Diagnosis
7.3.5.2.3. By End User

8. Europe PCOS Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By Diagnosis
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France PCOS Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment
8.3.1.2.2. By Diagnosis
8.3.1.2.3. By End User
8.3.2. Germany PCOS Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment
8.3.2.2.2. By Diagnosis
8.3.2.2.3. By End User
8.3.3. United Kingdom PCOS Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment
8.3.3.2.2. By Diagnosis
8.3.3.2.3. By End User
8.3.4. Italy PCOS Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Treatment
8.3.4.2.2. By Diagnosis
8.3.4.2.3. By End User
8.3.5. Spain PCOS Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Treatment
8.3.5.2.2. By Diagnosis
8.3.5.2.3. By End User

9. North America PCOS Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By Diagnosis
9.2.3. By End User
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States PCOS Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment
9.3.1.2.2. By Diagnosis
9.3.1.2.3. By End User
9.3.2. Mexico PCOS Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment
9.3.2.2.2. By Diagnosis
9.3.2.2.3. By End User
9.3.3. Canada PCOS Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment
9.3.3.2.2. By Diagnosis
9.3.3.2.3. By End User

10. South America PCOS Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment
10.2.2. By Diagnosis
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil PCOS Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Treatment
10.3.1.2.2. By Diagnosis
10.3.1.2.3. By End User
10.3.2. Argentina PCOS Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Treatment
10.3.2.2.2. By Diagnosis
10.3.2.2.3. By End User
10.3.3. Colombia PCOS Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Treatment
10.3.3.2.2. By Diagnosis
10.3.3.2.3. By End User

11. Middle East and Africa PCOS Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Treatment
11.2.2. By Diagnosis
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa PCOS Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Treatment
11.3.1.2.2. By Diagnosis
11.3.1.2.3. By End User
11.3.2. Saudi Arabia PCOS Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Treatment
11.3.2.2.2. By Diagnosis
11.3.2.2.3. By End User
11.3.3. UAE PCOS Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Treatment
11.3.3.2.2. By Diagnosis
11.3.3.2.3. By End User
11.3.4. Kuwait PCOS Treatment Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Treatment
11.3.4.2.2. By Diagnosis
11.3.4.2.3. By End User

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Competitive Landscape
15.1. Bristol-Myers Squibb Company
15.2. Bayer AG
15.3. Pfizer, Inc.
15.4. Abbott Laboratories
15.5. Merck & Co., Inc.
15.6. Sanofi SA
15.7. AstraZeneca Plc
15.8. Novartis AG
15.9. Teva Pharmaceutical Industries Limited
15.10. Ferring Pharmaceuticals, Inc.
15.11. Neurocrine Biosciences, Inc.
15.12. EffRx Pharmaceuticals SA
15.13. Mylan N.V.
15.14. Millendo Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Pfizer, Inc.
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Sanofi SA
  • AstraZeneca Plc
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Ferring Pharmaceuticals, Inc.
  • Neurocrine Biosciences, Inc.
  • EffRx Pharmaceuticals SA
  • Mylan N.V.
  • Millendo Therapeutics, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll